Assessing Variability in Vascular Response to Cocoa With Personal Devices: A Series of Double-Blind Randomized Crossover n-of-1 Trials

被引:7
|
作者
Bapir, Mariam [1 ]
Campagnolo, Paola [2 ]
Rodriguez-Mateos, Ana [3 ]
Skene, Simon S. [1 ]
Heiss, Christian [1 ,4 ]
机构
[1] Univ Surrey, Fac Hlth & Med Sci, Dept Clin & Expt Med, Guildford, England
[2] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem Sci, Guildford, England
[3] Kings Coll London, Fac Life Sci & Med, Sch Life Course & Populat Sci, Dept Nutr Sci, London, England
[4] Surrey & Sussex NHS Healthcare Trust, Vasc Dept, Redhill, England
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
基金
英国经济与社会研究理事会;
关键词
cocoa flavanols; n-of-1; blood pressure; pulse wave velocity; variability; flow-mediated dilation; FLAVANOL-RICH COCOA; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; FLAVONOID INTAKE; ASSOCIATIONS; FLAVAN-3-OLS; AMLODIPINE; RISK;
D O I
10.3389/fnut.2022.886597
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Controlled clinical intervention studies have demonstrated that cocoa flavanols (CF) can decrease blood pressure and arterial stiffness in healthy humans, although a large variability in the effect size across trials has been reported. In this study, we evaluated the intra- and inter-individual variability of responses to CF in everyday life using a series of n-of-1 trials in healthy free-living individuals with normal blood pressure carrying personal devices. In total, eleven healthy young humans participated in a repeated crossover randomized controlled double-blind n-of-1 trial. On 8 consecutive days, each volunteer consumed on alternating days 6 CF capsules (862 mg CF) on 4 days and 6 matched placebo capsules (P, 0 mg CF/day) on another 4 days in one of the two randomized sequences (CF-P-CF-P-CF-P-CF-P or P-CF-P-CF-P-CF-P-CF). On each day, the capsules were taken at the same time in the morning with breakfast after baseline measurements. Each subject was provided with an upper arm blood pressure monitor and a finger clip that measures pulse wave velocity (PWV). Measurements of blood pressure, heart rate, and PWV were taken at least hourly over 12 h during the day by the participants. On the first 2 days, measurements were performed under supervision to provide training. The overall mixed model analysis showed that CF significantly decreased 12-h systolic blood pressure and PWV by -1.4 +/- 0.3 mmHg and -0.11 +/- 0.03 m/s, respectively. Peak effects were observed within the first 3 h (1.5 h SBP: -4.9 +/- 2.2 mmHg, PWV: -0.32 +/- 0.17 m/s) and again after 8 h post-ingestion. Large inter-individual variation in responses was found [intra-cluster correlation coefficients (ICC): 0.41, 0.41]. When analyzing single individuals' datasets, there was also considerable between-day variation in individual responses that varied greatly between subjects (ICC: 0-0.30, 0-0.22, 0-0.45). Effect sizes inversely correlated with baseline blood pressure values both between- and within-subjects. The data confirm that cocoa can decrease blood pressure and arterial stiffness in everyday life when elevated within the normal range. The large inter- and intra-individual variation in responses calls for more personalized nutritional intervention strategies.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] DEXTROMETHORPHAN FOR THE TREATMENT OF NEUROPATHIC PAIN - A DOUBLE-BLIND RANDOMIZED CONTROLLED CROSSOVER TRIAL WITH INTEGRAL N-OF-1 DESIGN
    MCQUAY, HJ
    CARROLL, D
    JADAD, AR
    GLYNN, CJ
    JACK, T
    MOORE, RA
    WIFFEN, PJ
    PAIN, 1994, 59 (01) : 127 - 133
  • [2] INDIVIDUAL DOUBLE-BLIND CROSSOVER TRIALS FOR ASSESSING METHYLPHENIDATE RESPONSIVENESS
    MCBRIDE, MC
    KLORMAN, R
    ANNALS OF NEUROLOGY, 1983, 14 (03) : 360 - 360
  • [3] N-of-1 Double-Blind, Randomized Controlled Trial of Tramadol to Treat Chronic Cough
    Louly, Priscila Gebrim
    Medeiros-Souza, Patricia
    Santos-Neto, Leopoldo
    CLINICAL THERAPEUTICS, 2009, 31 (05) : 1007 - 1013
  • [4] A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes
    Samuel, Joyce P.
    Wootton, Susan H.
    Holder, Travis
    Molony, Donald
    PLOS ONE, 2022, 17 (06):
  • [5] Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials
    Yi-ming Chen
    Jie-min Deng
    Yi Wen
    Bin Chen
    Jiang-tao Hou
    Bin Peng
    Shi-jing Zhang
    Hong Mi
    Qi-long Jiang
    Xia-lin Wu
    Feng-bin Liu
    Xin-lin Chen
    Trials, 21
  • [6] Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials
    Chen, Yi-ming
    Deng, Jie-min
    Wen, Yi
    Chen, Bin
    Hou, Jiang-tao
    Peng, Bin
    Zhang, Shi-jing
    Mi, Hong
    Jiang, Qi-long
    Wu, Xia-lin
    Liu, Feng-bin
    Chen, Xin-lin
    TRIALS, 2020, 21 (01)
  • [7] Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies
    Blackston, J. Walker
    Chapple, Andrew G.
    McGree, James M.
    McDonald, Suzanne
    Nikles, Jane
    HEALTHCARE, 2019, 7 (04) : 1 - 13
  • [8] Double-blind randomized N-of-1 trial of transcranial alternating current stimulation for mal de debarquement syndrome
    Cha, Yoon-Hee
    Gleghorn, Diamond
    Doudican, Benjamin Chipper
    PLOS ONE, 2022, 17 (02):
  • [9] Efficacy and Safety of Ginkgo Biloba Pills for Coronary Heart Disease with Impaired Glucose Regulation: Study Protocol for a Series of N-of-1 Randomized, Double-Blind, Placebo-Controlled Trials
    Sun, Mingyue
    Chai, Lulu
    Lu, Fang
    Zhao, Yang
    Li, Qingna
    Cui, Boya
    Gao, Rui
    Liu, Yue
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [10] Are brand-name and generic warfarin interchangeable? Multiple N-of-1 randomized, crossover trials
    Pereira, JA
    Holbrook, AM
    Dolovich, L
    Goldsmith, C
    Thabane, L
    Douketis, JD
    Crowther, MA
    Bates, SM
    Ginsberg, JS
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1188 - 1193